Overview
Karl Kasamon is a Hematologist practicing medicine in Columbia, Maryland.
His clinical expertise encompasses Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), RUNX1 Familial Platelet Disorder, and Sickle Cell Disease.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
5450 Knoll North Dr Ste 140, Columbia, MD 21045
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine. Dr. Brodsky is currently accepting new patients.
Johns Hopkins Bayview Medical Center
Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs. Dr. Hann is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Hann is board certified in American Board Of Internal Medicine. Dr. Hann is currently accepting new patients.
Office
Brigitte Widemann is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Widemann is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Neurofibromatosis, Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Medullary Thyroid Carcinoma, and Thyroidectomy.
Frequently Asked Questions about Dr. Karl M. Kasamon
How do I make an appointment with Dr. Karl M. Kasamon?
You can book an appointment with Dr. Karl M. Kasamon by calling their office at 410-350-3386. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Karl M. Kasamon a top-rated expert for Schnitzler Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Karl M. Kasamon is classified as an Experienced expert for Schnitzler Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Karl M. Kasamon specialize in?
While Dr. Karl M. Kasamon is a Hematology, they have specific expertise in Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), and RUNX1 Familial Platelet Disorder. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AnemiaDr. Kasamon isExperienced. Learn about Anemia.
- Atypical Hemolytic Uremic Syndrome (aHUS)Dr. Kasamon isExperienced. Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
- Autoimmune Hemolytic AnemiaDr. Kasamon isExperienced. Learn about Autoimmune Hemolytic Anemia.
- D-Plus Hemolytic Uremic SyndromeDr. Kasamon isExperienced. Learn about D-Plus Hemolytic Uremic Syndrome.
- Essential ThrombocythemiaDr. Kasamon isExperienced. Learn about Essential Thrombocythemia.
- Hemangioma Thrombocytopenia SyndromeDr. Kasamon isExperienced. Learn about Hemangioma Thrombocytopenia Syndrome.
- Hemolytic-Uremic SyndromeDr. Kasamon isExperienced. Learn about Hemolytic-Uremic Syndrome.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Kasamon isExperienced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Kasamon isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Myeloproliferative Neoplasms (MPN)Dr. Kasamon isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Pulmonary EmbolismDr. Kasamon isExperienced. Learn about Pulmonary Embolism.
- RUNX1 Familial Platelet DisorderDr. Kasamon isExperienced. Learn about RUNX1 Familial Platelet Disorder.
- Schnitzler SyndromeDr. Kasamon isExperienced. Learn about Schnitzler Syndrome.
- Sickle Cell DiseaseDr. Kasamon isExperienced. Learn about Sickle Cell Disease.
- Smoldering Multiple MyelomaDr. Kasamon isExperienced. Learn about Smoldering Multiple Myeloma.
- ThrombocytopeniaDr. Kasamon isExperienced. Learn about Thrombocytopenia.

